AVIR (Atea Pharmaceuticals) Other Current Receivables: $0.00 Mil (As of Mar. 2026)


AVIR Atea Pharmaceuticals Inc AVIR
28 GF Score
Price $4.98
! 3 Warning Signs
View Full Analysis

What is Atea Pharmaceuticals Other Current Receivables?

Atea Pharmaceuticals AVIR +4.29% 28 Other Current Receivables is $0.00 Mil as of Mar. 2026. GuruFocus rates AVIR with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Atea Pharmaceuticals's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.00 Mil.

Atea Pharmaceuticals Other Current Receivables Related Terms

Atea Pharmaceuticals Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Atea Pharmaceuticals's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atea Pharmaceuticals Other Current Receivables Chart

Atea Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Atea Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AVIR
28GF Score
Atea Pharmaceuticals Inc AVIR
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atea Pharmaceuticals Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Atea Pharmaceuticals (AVIR) has a Other Current Receivables of $0.00 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Atea Pharmaceuticals and its competitors.
Is Atea Pharmaceuticals' Other Current Receivables too high?
Atea Pharmaceuticals' current Other Current Receivables is $0.00 Mil. Overall, Atea Pharmaceuticals has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Atea Pharmaceuticals' Other Current Receivables compare to VNDA and TENX?
Atea Pharmaceuticals' Other Current Receivables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Atea Pharmaceuticals and its competitors. Atea Pharmaceuticals's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atea Pharmaceuticals stock overvalued right now?
Atea Pharmaceuticals (AVIR) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Atea Pharmaceuticals' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Atea Pharmaceuticals (AVIR), the current Other Current Receivables is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atea Pharmaceuticals Business Description

Address 225 Franklin Street, Suite 2100, Boston, MA, USA, 02110
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
28GF Score

Get the complete analysis for AVIR

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.98
Price